Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Beyond the Abstract - Second-line therapy for refractory renal-cell carcinoma ... - UroToday PDF Print

Beyond the Abstract - Second-line therapy for refractory renal-cell carcinoma ...
UroToday
Worth mentioning is the opportunity to use sorafenib as first-line in selected patient populations such as the elderly or patients with comorbidities including hypertension, left ventricular ejection fraction abnormalities, and renal failure.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.